Rameez Husain Chaviwala
Family Medicine · Schaumburg, ILNPI 1033633573
Payments from drug & device makers
Across 285 payments — averaging $16.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$722
- GSK$646
- Daiichi Sankyo Inc.$645
- Novo Nordisk$564
- Bayer$557
- Amgen$236
- plus $1K from 26 others
What the payments were for
- Food & beverage$4,74599%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 45 | $722 |
| GSK | 40 | $646 |
| Daiichi Sankyo Inc. | 34 | $645 |
| Novo Nordisk | 35 | $564 |
| Bayer | 31 | $557 |
| Amgen | 15 | $236 |
| Lilly USA, LLC | 12 | $190 |
| Otsuka America Pharmaceutical, Inc. | 8 | $173 |
| Pfizer | 9 | $149 |
| Nestle Healthcare Nutrition Inc. | 10 | $137 |
| AstraZeneca(2 entities) | 8 | $128 |
| Sanofi-aventis U.S. LLC | 5 | $75 |
| Astellas Pharma US Inc | 4 | $63 |
| Alnylam Pharmaceuticals Inc. | 3 | $51 |
| Dexcom, Inc. | 3 | $47 |
| Eisai Inc. | 2 | $37 |
| Boehringer Ingelheim | 2 | $35 |
| Sumitomo Pharma America, Inc. | 2 | $34 |
| Actelion Pharmaceuticals US, Inc. | 1 | $32 |
| Si-bone, Inc. | 2 | $32 |
| Exact Sciences | 2 | $31 |
| Axsome Therapeutics, Inc. | 2 | $30 |
| Merck | 1 | $22 |
| Phadia US Inc. | 1 | $21 |
| Abbott | 1 | $19 |
| Sunovion Pharmaceuticals Inc. | 1 | $19 |
| Lundbeck LLC | 1 | $16 |
| Shield Therapeutics Inc | 1 | $16 |
| Biogen | 1 | $15 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Esperion Therapeutics, Inc. | 1 | $11 |
How this compares
$4,778 in reported general payments places this provider in the 90th percentile of 4,116 family medicine providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 192 | $149,123 |
| JardianceEmpagliflozin | 114 | $113,857 |
| OzempicSemaglutide | 81 | $89,310 |
| MounjaroTirzepatide | 50 | $50,199 |
| XareltoRivaroxaban | 63 | $42,830 |
| TrulicityDulaglutide | 39 | $36,485 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 48 | $29,924 |
| FarxigaDapagliflozin Propanediol | 35 | $28,025 |
| EntrestoSacubitril/Valsartan | 27 | $23,563 |
| JanuviaSitagliptin Phosphate | 20 | $13,264 |
| OxycontinOxycodone Hcl | 15 | $12,676 |
| MultaqDronedarone Hcl | 14 | $11,239 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 37 | $11,138 |
| BrilintaTicagrelor | 16 | $10,507 |
| Soliqua 100-33Insulin Glargine/Lixisenatide | 11 | $10,134 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $149 | $149,123192 claims |
| Boehringer IngelheimJardiance, Tradjenta | $35 | $120,604128 claims |
| Novo NordiskOzempic | $564 | $89,31081 claims |
| Lilly USA, LLCMounjaro, Trulicity | $190 | $86,68489 claims |
| GSKTrelegy Ellipta, Anoro Ellipta, Breo Ellipta | $646 | $41,22874 claims |
| AstraZenecaFarxiga, Brilinta | $128 | $38,53251 claims |
| Sanofi-aventis U.S. LLCMultaq, Soliqua 100-33 | $75 | $21,37225 claims |
| MerckJanuvia | $22 | $13,26420 claims |
| AbbVieSynthroid | $722 | $2,20537 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,116 family medicine providers in Illinois.
Other family medicine in Schaumburg
- Sabrina IndykSchaumburg$79K
- Daniel BruneCreve Coeur$15M
- Ali BajwaSpringfield$5.8M
- John ElsenEvergreen Park$5M
- Manohar JethaniBerwyn$4.9M
- Tiffany NguyenSkokie$3.9M
- Bradley TorphyChicago$3M
- Diana WidicusRochester$2.6M
- Nicholas WeberEureka$2.5M
- Stanley KochMorton$2.3M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.